MEDI 114-3-Amino benzo[d]isoxazoles as novel multitargeted receptor tyrosine kinase inhibitors

被引：0

作者：

Ji, Zhiqin ^{[1
]}

Ahmed, Asma A. ^{[2
]}

Albert, Daniel H. ^{[1
]}

Bouska, Jennifer J. ^{[1
]}

Bousquet, Peter F.

Cunha, George A. ^{[2
]}

Glaser, Keith B. ^{[1
]}

Johnson, Eric F. ^{[1
]}

Guo, Jun ^{[1
]}

Li, Junling ^{[1
]}

Marcotte, Patrick A. ^{[1
]}

Moskey, Maria D. ^{[2
]}

Pease, Lori J. ^{[1
]}

Soni, Nirupama B. ^{[1
]}

Stewart, Kent D. ^{[1
]}

Tapang, Paul ^{[1
]}

Yates, Melinda S. ^{[1
]}

Davidsen, Steven K. ^{[1
]}

Michaelides, Michael R. ^{[1
]}

机构：

[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA

[2] Abbott Biores Ctr, Worcester, MA 01605 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 232卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

114-MEDI

引用

页数：1

共 50 条

[41] Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors
Huang, He
Jia, Qi
Ma, Jingui
Qin, Guangrong
Chen, Yingyi
Xi, Yonghua
Lin, Liping
Zhu, Weiliang
Ding, Jian
Jiang, Hualiang
Liu, Hong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (05) : 1982 - 1988
[42] The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β-Dependent Pathway
Hernandez-Davies, Jenny E.
Zape, Joan P.
Landaw, Elliot M.
Tan, Xiaolin
Presnell, Ajia
Griffith, Diana
Heinrich, Michael C.
Glaser, Keith B.
Sakamoto, Kathleen M.
MOLECULAR CANCER THERAPEUTICS, 2011, 10 (06) : 949 - 959
[43] Novel 2-amino-4-anilino-6-methyl-5-substituted pyrrolo[2,3-D]pyrimidines as potential receptor tyrosine kinase inhibitors.
Gangjee, A
Jain, H
Ihnat, M
Kamat, S
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U13 - U13
[44] Ligand-based Discovery of Novel Small Molecule Inhibitors of RON Receptor Tyrosine Kinase
Zarei, Omid
Faham, Najme
Vankayalapati, Hariprasad
Raeppel, Stephane L.
Welm, Alana L.
Hamzeh-Mivehroud, Maryam
MOLECULAR INFORMATICS, 2022, 41 (01)
[45] Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitors
Chen, Chih-Hung
Lee, On
Yao, Chung-Niang
Chuang, Meng-Yun
Chang, Yow-Lone
Chang, May-Hua
Wen, Yen-Fang
Yang, Wan-Hsu
Ko, Ching-Huai
Chou, Nien-Tzu
Lin, Mai-Wei
Lai, Chin-Pen
Sun, Chung-Yuan
Wang, Ling-mei
Chen, Yen-Chun
Hseu, Tzong-Hsiung
Chang, Chia-Ni
Hsu, Hui-Chun
Lin, Hui-Chi
Chang, Yu-Li
Shih, Ying-Chu
Chou, Shuen-Hsiang
Hsu, Yi-Ling
Tseng, Hsiang-Wen
Liu, Chih-Peng
Tu, Chia-Mu
Hu, Tsan-Lin
Tsai, Yuan-Jang
Chen, Ting-Shou
Lin, Chih-Lung
Chiou, Shu-Jiau
Liu, Chung-Cheng
Hwang, Chrong-Shiong
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (20) : 6129 - 6132
[46] Characteristics of HIV-associated lung cancer and the use of novel receptor tyrosine kinase inhibitors
Samani, A.
Dalla Pria, A.
Norton, J.
Gallagher, P.
Froggatt, J.
Davis, T. N.
Bower, M.
HIV MEDICINE, 2017, 18 : 36 - 36
[47] Discovery of 4-Benzylamino-Substituted α-Carbolines as a Novel Class of Receptor Tyrosine Kinase Inhibitors
Krug, Martin
Wichapong, Kanin
Erlenkamp, German
Sippl, Wolfgang
Schaechtele, Christoph
Totzke, Frank
Hilgeroth, Andreas
CHEMMEDCHEM, 2011, 6 (01) : 63 - 72
[48] SYNTHESIS OF NOVEL BENZOXAZINONE COMPOUNDS AS EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS
Chen, Shaopeng
Li, Xuemin
Wan, Shengbiao
Jiang, Tao
SYNTHETIC COMMUNICATIONS, 2012, 42 (19) : 2937 - 2946
[49] 2D, 3D and in vivo models of head and neck cancer identify novel correlates of resistance to epidermal growth factor receptor tyrosine kinase inhibitors
Box, C.
Baker, L. C. J.
Beloueche-Babari, M.
Rogers, S. J.
Box, G. M.
Harrington, K. J.
Leach, M. O.
Robinson, S. P.
Eccles, S. A.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S772 - S772
[50] Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d] isoxazole or 3-aminoindazole scaffold
Jiang, Xiaolong
Liu, Hongyan
Song, Zilan
Peng, Xia
Ji, Yinchun
Yao, Qizheng
Geng, Meiyu
Ai, Jing
Zhang, Ao
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (03) : 564 - 578

← 1 2 3 4 5 →